期刊文献+

心力衰竭患者快速检测NT-proBNP的临床意义 被引量:6

Clinical Significance of Rapid Assay of NT-proBNP in Patients with Heart Failure
暂未订购
导出
摘要 目的 探讨心力衰竭(HF)患者N末端B型脑钠钛前体(NT-proBNP)及血浆肌酸激酶同工酶(CK-MB)与肌酸激酶(CK)比值(B/K)的动态变化及临床意义。方法用Staus FirstTMNT-proBNP测定仪快速测定85例不同病因所致的HF患者和50例同期非心血管病对照组患者的NT—proBNP及血浆CK-MB与CK的比值(B/K)。结果HF患者NT-proBNP水平较对照组升高,有统计学意义(P〈0.05);各NYHA分级中CK-MB、CK均在正常范围;而NT.proBNP随心功能不全的加重逐渐升高,心功能Ⅰ~Ⅳ级患者组各组间血浆NT-proBNP差异均有统计学意义(P〈0.05);心功能不全Ⅲ、Ⅳ级患者B/K比值较Ⅰ、Ⅱ级、对照有统计学意义(P〈0.05)。ROC曲线表明:NT-proBNP曲线下面积为0.938,若选取NT—proBNP188pg/ml作为心衰诊断的临界值,敏感性为88.2%,特异性为84%,说明NT-proBNP对HF有较高的诊断效率。结论NT.proBNP检测可作为HF急诊生化项目,可与B/K比值作为HF早期预测及中晚期预后指标。
出处 《现代诊断与治疗》 CAS 2009年第2期69-71,共3页 Modern Diagnosis and Treatment
  • 相关文献

参考文献6

  • 1Kawai K,Hata K,Takaoka H,et al. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopethy durin8 beta-blocker therapy :a potential of honnoneguided treatment[ J]. Heart, 2001,141(6) :925-932.
  • 2Teutamoto T, Wada A. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:prognostlc role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction [J ]. Circulation, 997,96 : 509- 516.
  • 3Tulevsld II,Groanink M, Van Der Wall EE ,et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload :correlation between plasma neurohonnones and right vantricular dysfunction[ J]. Heart,2001,86( 1 ) :27-30.
  • 4Hunt PJ, Riehards AM, Nicholta MG, et al. Immunoreactive amino terminal pro brain natriuretlc peptideta(NT-proBNP) new marker of cardiac impainnent[J]. Clin Endccrinol,1997,47(3) :287-296.
  • 5Jmn SK, Lindahl B, Siegbahn A, et al N-terminal pro brain natriuretie peptide and other risk nmrkers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease;a global utilization of strategies to open occluded arteries (GUSTO) -Iv substudy[ J]. Circulation ,2003,108 (3) :275-281.
  • 6王瑶,陶则伟,陆贤,黄元伟.B型钠尿肽的研究进展[J].心脏杂志,2003,15(6):555-557. 被引量:41

二级参考文献5

共引文献40

同被引文献63

  • 1孙宝贵,汪玮.慢性心力衰竭治疗中血管紧张素转换酶抑制剂的应用[J].中国实用内科杂志,2005,25(7):582-584. 被引量:56
  • 2刘亚欣,周宪梁.β-肾上腺素能受体阻滞剂治疗慢性心力衰竭的研究进展[J].中国分子心脏病学杂志,2004,4(4):243-248. 被引量:13
  • 3吴学思.正确掌握β受体阻滞剂在慢性心力衰竭的应用时机[J].中华心血管病杂志,2006,34(9):769-771. 被引量:63
  • 4祝烨.慢性心力衰竭治疗进展[J].现代临床医学,2007,33(2):148-150. 被引量:7
  • 5余浩,李娇.曲美他嗪对急性病毒性心肌炎的心肌保护作用观察[J].心脏病杂志,2010,22(3):406-407.
  • 6王燕,汤明荣.272例心功能不全患者NT-proBNP检测结果的临床分析[J].放射医学杂志,2011,24(1):80.
  • 7Shim S H, Braunwald E, Bristow M R. Congestive heart failure: fifty years of progress[J]. Circulation, 2000, 102 (20 Suppl 4) : IV14.
  • 8Martinez A S, Saef J, Paszczuk A, et ah Implementation of a pharmacist-managed heart failure medication titration clinic [J]. AmJ Health Syst Pharm, 2013, 70(12): 1070.
  • 9Meuwese C L, Kirkels J H, de Jonge N, et ah Beta-blocker therapy in unstable severe heart failure, evidence or experi- ence[J]. Neth Heart J, 2013, 21(1) : 3.
  • 10Sidorenko B A, Preobrazhensky D V, Batyraliev T A, et al. Contemporary approaches to diagnosis and management of chronic heart failure (summary of the American College of Cardiology/American Heart Association Guidelines ) [ J ]. Kardiologiia, 2002, 42(6): 65.

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部